Medicines Australia
Jump to navigation
Jump to search
Medicines Australia is a lobby group for major Australian pharmaceutical companies. It was previously known as the Australian Pharmaceutical Manufacturers' Association.
Medicines Australia is a member association of the International Federation of Pharmaceutical Manufacturers & Associations[1].
Contents
Personnel
- Ian Chalmers CEO
- Will Delaat, Chairman
Former Personnel
- Kieran Schneemann (CEO) 2002-2006
- Alan Evans (Former CEO) - October 2002
- John Young, former Chairman
Members
- 3M Pharmaceuticals
- Abbott Australasia
- Alcon Laboratories (Australia)
- Allergan Australia
- AMGEN Australia
- AstraZeneca
- Bayer Australia
- Biogen Idec Australia
- Boehringer Ingelheim
- Bristol-Myers Squibb Australia
- CSL Limited
- Eli Lilly Australia
- Gilead Sciences
- GlaxoSmithKline Australia
- Ipsen
- Janssen-Cilag
- Lundbeck Australia
- Merck Sharp & Dohme (Aust)
- Mundipharma
- Novartis Pharmaceuticals Australia
- Novo Nordisk Pharmaceuticals
- Organon (Australia)
- Pfizer Australia
- Pharmion
- Roche Products
- sanofi-aventis Group
- Schering
- Schering-Plough
- Serono Australia
- Solvay Pharmaceuticals
- Wyeth Australia
Lobbyists
Other SourceWatch resources
- Medicines Australia's Code of Conduct
- United States-Australia Free Trade Agreement and the Pharmaceutical Benefits Scheme
- United States-Australia Free Trade Agreement
Contact details
Medicines Australia
Level 1, 16 Napier Close
DEAKIN ACT 2600
Ph: (02) 6282 6888
Fax: (02) 6282 6299
Web: http://www.medicinesaustralia.com.au/
Articles and Resources
Sources
- ↑ "International Federation of Pharmaceutical Manufacturers & Associations - Member Associations", International Federation of Pharmaceutical Manufacturers & Associations web site accessed July 2009.
- ↑ "Australian Government Lobbyists Register", Australian Government Lobbyists Register accessed November 2009.
Related SourceWatch Articles
External Articles
- "Doctors given assurances on educational events", Media Release, February 27, 2008.
